China Pharmaceutical Group Co., Ltd., namely China Pharmaceutical Group, is the largest pharmaceutical and health industry group with the most complete industrial chain and the strongest comprehensive strength in China directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It focuses on distribution, retail, research and development and production of health-related products, such as preventive treatment and diagnostic care.
Pharmaceutical Group has a pharmaceutical distribution network covering 365,438+0 provinces, autonomous regions and municipalities directly under the Central Government and 30 distribution centers that meet international standards. It is the largest biological R&D and production enterprise in China, and undertakes more than 80% of the production tasks of vaccines under the national immunization program.
Extended data:
China Pharmaceutical Group has established production bases and medicinal materials bases for biopharmaceuticals, narcotic psychotropic drugs, anti-infective drugs, anti-tumor drugs, cardiovascular and cerebrovascular drugs, and respiratory drugs, as well as production lines that have passed FDA, EU certification and WHO pre-certification and meet international standards.
Among them, biomedical R&D and its production enterprises can produce all legal vaccines for immunization programs in China, undertake more than 80% of the production tasks of vaccines for national immunization programs, and are also the sixth largest vaccine supplier in the world.
China Pharmaceutical Group has built a complete health industrial chain of traditional Chinese medicine, including cultivation, scientific research, production and sales of traditional Chinese medicine, producing more than 900 kinds of prescription drugs, 5 Chinese time-honored brands/kloc-0, and 4 intangible cultural heritage products, which has promoted traditional Chinese medicine.
China Pharmaceutical Group has cultivated 26 exhibition brands such as China International Medical Device Expo, covering the whole industrial chain and various sub-sectors of human health, and has become a platform for cooperation and exchange in the fields of medicine, medical care and health in China, which has promoted the development of the entire pharmaceutical industry.
China Pharmaceutical Group has successfully explored the new model of "Great Health Concept Store" and established more than 4,500 retail chain pharmacies including Guo Da, Golden Elephant, Dadesheng and Tianyitang.
A medical service network has been established, and several regional medical clusters such as Henan, Hubei and Liaoning have been formed. There are 23 medical institutions, including 3 tertiary hospitals and 6 secondary hospitals, with a total number of beds of nearly 1 10,000, so that more people can enjoy convenient medical and health services.
China Pharmaceutical Group has established 26 joint ventures with internationally renowned pharmaceutical enterprises, conducted trade with more than 60 countries along the Belt and Road, established trade relations with more than 20 countries and regions in the world, and further broadened cooperation channels.
The Japanese encephalitis live vaccine with independent intellectual property rights became the first vaccine product in China that was pre-certified by the World Health Organization, and was included in the procurement of United Nations agencies, thus benefiting the whole world. Establish overseas industrial bases in Vietnam and Malaysia, build hospitals and mobile clinics in Myanmar and Cambodia, and make positive contributions to improving the health and well-being of local people and promoting employment.
References:
Baidu Encyclopedia-China Pharmaceutical Group